This is Bayer 2007/2008 · • Elevit ®, a vitamin ... welfare and, if there are benefits to be...

Bayer Healthcare 0�

This is Bayer 2007/2008Australia • New Zealand

About BayerA global enterprise, Bayer has core competencies in the areas of health care, nutrition and high-tech materials. In Australia and New Zealand, Bayer has invested significantly in local research and manufacturing for more than 80 years.

Contents

People, partnerships 0� and innovation

Bayer HealthCare 0�

Bayer CropScience 06

Bayer MaterialScience �0

Our products ��

Spotlight on New Zealand �4

Our people �6

Community & environment �8

Management report ��

Bayer at a glance �4

This is Bayer 2007/08

About Bayer

Bayer’s products and services are designed to benefit people and improve their quality of life. Known worldwide as an inventor company, Bayer continues to strengthen its position through research and innovation.

Divided into three business groups, Bayer HealthCare, Bayer CropScience and Bayer MaterialScience, Bayer employs 830 people in Australia and New Zealand, and �06,000 people worldwide. In �007 Bayer generated A$7�3 million (NZ$8�� million) in revenue in Australia and New Zealand.

Bayer Australia and New Zealand is a fully owned subsidiary of Bayer AG based in Leverkusen, Germany. Research and development are key to Bayer’s success and most of today’s business activities are based on Bayer’s own innovations.

Bayer has a competent and committed workforce and upholds the principle of sustainable development, which places corporate social responsibility on an equal level with economic and ecological performance.

2007 in review Just some of Bayer’s innovations and milestones throughout Australia and New Zealand from �007:

• Animal Health became the market leader in the companion animal business in Australia.

• There was a successful local integration after Bayer’s global acquisition of Schering AG in �006.

• The moratoria on the commercialisation of genetically modified canola were lifted in Victoria and New South Wales.

• Cheetah® Gold became the best performing cereal herbicide (in budget achievement) in its first year in tough market conditions.

• Liberty Link® Cotton was launched into the cotton market, making Australia the second country globally to launch a Bayer biotech product in this crop.

• Bridging the gap between rubber and plastic, Desmopan plays a key role in the highly durable and water resistant Dosh Wallet.

• Water based polyurethanes – Bayhydrol® and Bayhydur – were used to make environmentally friendly surfboards.

Dr Louise Coats, veterinarian, Phil James, dairy farmer with Janie Martin, Bayer Regional Manager, Carrie and Russell Davenport, dairy farmers at Ngatea, New Zealand. Full story on page �5.


People, partnerships and innovation

0�

Growth and innovation, combined with support for the environment and social responsibility, will be the focus for �008.

A financially successful year, �007 was one of highs for Bayer Australia and New Zealand.

As I begin my first year as Senior Bayer Representative, I am reminded of the busy times we experienced and the major projects we undertook over the past �8 months. Clearly, the largest of these was the global acquisition of the pharmaceutical company, Schering AG. Then, while busy establishing the new organisation, Bayer Schering Pharma, we divested the Diagnostics division to Siemens Medical and the Wolff Walsrode business to Dow. It is the Bayer people who made these projects successful and who worked tirelessly to build a new (and very successful) pharmaceuticals business.

Being new to the Bayer family myself (through the Schering acquisition) I have been impressed since day one with the commitment of the people, the businesses they manage through excellent partnerships, and their commitment to innovation and new ideas.

As Bayer continues to create value through innovation and high quality products, I expect that �008 will be characterised by maintaining a successful and sustainable business while following my personal passion for environmental issues. Bayer’s already strong reputation in the area of community involvement continues to grow with our signing of the Australian Greenhouse Challenge to reduce carbon emissions. In �008, we shall also develop the local content of the Bayer Climate Change Program.

Sadly, in �007 we farewelled my predecessor Sam Howard who passed away suddenly in August after battling cancer. Sam was a popular leader and a gentleman. He is sorely missed. His wife and daughters remain in our thoughts.

Hans-Dieter HausnerSenior Bayer RepresentativeAustralia and New Zealand

0� Bayer HealthCare


0� HealthCare

HealthCareBayer HealthCare researches, develops, manufactures and markets products that improve and protect the health of people and animals worldwide.

Bayer HealthCare covers the fields of prescription medicines, animal health, and over-the-counter health products.

A foremost innovator in pharmaceutical and medical products, Bayer HealthCare has more than 50,000 people working globally and over 370 in Australia and New Zealand. Bayer HealthCare has a market leading position in the Animal Health and Consumer Care divisions and is renowned for its innovations in pharmaceuticals. The development pipeline contains more than 30 substances for the treatment of widespread diseases.

In �007 the pharmaceuticals division completed the integration of the Schering business, with New Zealand one of the first countries worldwide ready to start operating as the Bayer Schering Pharma division.

Bayer HealthCare’s financial results are detailed on pages ��-�3.

Milestones • Animal Health became the market

leader in the companion animal business in Australia.

• Animal Health introduced Accelerate, a partnership program with veterinary practices that encompasses a marketing scheme and accredited training programs.

• Consumer Care exceeded its sales target by �% in �007. This was an ��% increase on the previous year with the market growing only 3%.

• Berocca®, a well established energy brand, had excellent sales growth of �3% on the previous year.

• Elevit®, a vitamin supplement for pre-conception, pregnancy and breastfeeding doubled sales in one year.

• Betaferon® continues to be Bayer Schering Pharma’s largest-selling medication in Australia and the number one treatment for people with multiple sclerosis.

• Mirena®, an intrauterine levonorgestrel delivery system (IUS) for long-term contraception, was indicated as a treatment for idiopathic menorrhagia.

Areas of expertise

Bayer HealthCare incorporates four divisions:

Bayer Schering Pharma is a pharmaceutical division with six business units: Women’s Healthcare, Specialized Therapeutics, Primary Care and Men’s Health, Oncology, Hematology and Cardiology, and Diagnostic Imaging.

Animal Health develops products for both companion and farm animals, including animal pain relief.

Consumer Care develops and markets over-the-counter health products such as multivitamins, energy supplements, pain relief and dermatological products.

Diabetes Care is one of the world’s market leaders in the field of blood glucose monitoring systems.

HealthCare 03

Pain relief for sheep a better choice for wool producersBeginning with Aspirin, Bayer has a ��0 year history of human pain relief. Today, Bayer also contributes to pain minimisation for animals with a product for the broad scale management of pain experienced by sheep during mulesing*.

Will Roberts, sheep breeder and Chairman of the Australian Stud Merino Breeders Association.


Bayer’s product Tri-Solfen® can be applied as a spray to the mulesing wound. It reduces pain and blood loss and improves wound healing. This means faster and fuller recovery for the lambs. It also means more efficient livestock management, as mulesing without pain relief is traumatic for sheep and causes pain, stress and weight loss.

Bayer’s Better ChoicesTM program helps promote the wool of producers who are doing all they can to ensure the welfare of their sheep during mulesing. Better ChoicesTM registers Australian wool producers in an audited sheep welfare program when they treat all their lambs with Tri-Solfen®. This gives wool producers access to an educational program as well as demonstrating their commitment to progressive farming to wool brokers

and buyers. This is increasingly important as more people along the buying chain are concerned about pain management of sheep during fibre production. This includes textile makers, garment manufacturers, fashion houses and the end consumer.

Will Roberts runs a large sheep stud in Queensland and is the Chairman of the Australian Stud Merino Breeders Association. A Better ChoicesTM farmer, Will says that “from a pain relief point of view it’s a huge step forward.” And it’s not just the sheep who are benefiting according to Will, “When they’re doing better, we’re making money.”

Dr David Hucker, specialist veterinarian in the western district of Victoria agrees. “Sheep farmers are very concerned about animal welfare and, if there are benefits to be found, they are keen to try the options,” says David. “Locally, many of my clients have included pain relief into their lamb marking routine to better the lambing experience.”

David says that the lambs are less stressed and show much more natural behaviour. “They jump out of

the cradle, look around for their mother a couple of hundred yards away, walk over and commence suckling. Returning them to the paddock after the lamb marking was also easier.”

*Mulesing is an essential surgical procedure (primarily for merino

sheep) that reduces the risk of infection and death from fly strike.


04 HealthCare

News for men and fertilityMenevit® is a new antioxidant formulation designed to support sperm health.

Many things, including smoking and exposure to environmental pollutants, are thought to cause the body to produce more ‘free radicals’ than are needed. Free radicals at an increased level can harm sperm quality and production, and contribute to difficulties in conceiving. Bayer HealthCare’s new product, Menevit®, contains antioxidants that work by neutralising these sperm damaging free radicals.

In a recent clinical study, Menevit® significantly increased conception for couples undergoing IVF ICSI (intracytoplasmic sperm injection) when the male partner took one tablet daily for three months.

Peter and Mary of Adelaide were a couple who were having difficulties

conceiving. “We had been married for seven years and decided we really wanted a family and obviously felt that we could just have a family like that, and tried, but it just wasn’t to be,” said Peter.

Peter and Mary’s fertility specialist had found that their problem was mainly with sperm quality. Semen analysis had shown high degrees of DNA damage. Even with IVF, things didn’t improve for Peter and Mary. After six years and no success, Peter and Mary nearly gave up on the possibility of being biological parents.

That’s when their fertility specialist suggested that Peter take Menevit®. He felt they had nothing to lose. He says, “I was back in the game again.” Peter took the tablets every

day for the next three months, long enough for him to produce new sperm for yet another IVF cycle.

Mary fell pregnant and gave birth to two beautiful baby girls. Mary says, “It’s amazing to think that the resolution was so simple in the end; that Peter just had to take a tablet for three months that had no side effects and bingo!”

Peter says, “This is a great ending to a pretty long journey I guess!”

Menevit® will be available shortly over the counter through pharmacies in Australia.

A great ending to a pretty long journey.

Taking women’s health seriouslyHelen Lawson lived for many years with the extreme tiredness that chronic anaemia causes in women with menorrhagia.

HealthCare 05


Dr Karuna Raja, gynaecologist, with patient Helen Lawson from Bayer Schering Pharma.

Menorrhagia is defined as a menstrual blood loss of over 80ml per cycle and affects �0-�5% of women. It is a leading cause of iron deficiency anaemia in western women. Helen also wanted a reliable birth control method that didn’t give her unwelcome side effects such as headaches and weight gain.

After struggling with feeling exhausted for many years Helen sought treatment from her gynaecologist and obstetrician Dr Karuna Raja. “Menstrual problems can be very debilitating for women, affecting both their personal and working lives. These problems cause a lot of suffering in the community,” says Dr Raja. “I see many women across the spectrum who are badly affected by menstrual problems. From �6-year-olds with very painful periods to 50-year-old women experiencing heavy bleeding.”

Helen already knew about an intrauterine levonorgestrel delivery system (IUS) option because of her work as a sales representative with Bayer Schering Pharma and it turned out that Dr Raja thought that it would be a good option for her.

Helen’s life has been transformed since her treatment, “I am no longer exhausted from anaemia. Before, no supplement could get my iron levels up enough and the tiredness used to affect every part of my life. It made my previous work as a nurse doing shift-work very difficult.”

Mirena® can be used for long-term contraception, as a treatment for idiopathic menorrhagia and as the progestogen component of hormone replacement therapy. It offers five

years continuous treatment and can give women up to a 93%

decrease in their menstrual blood flow while providing

contraception. The device has side effects, including

irregular bleeding patterns during the first three to five months after an uncomfortable insertion. Insertion and removal of the device should only be performed by a trained doctor.

Mirena® is available in Australia on the Prescription Benefits Scheme (PBS) and in New Zealand for women who meet certain criteria.

Consult your doctor about options if you experience menorrhagia.

CropScienceBayer CropScience aims to be recognised as being integral to the sustainable production of all food and fibre in Australia and New Zealand.

06 CropScience


Through world leadership in the areas of crop protection, non-agricultural pest control, seeds and plant biotechnology, Bayer CropScience continues to make a difference to the lives of people in the agricultural sector. Bayer is committed to the research and development of environmentally sustainable solutions in the areas of chemistry, biotechnology and seeds, both globally and locally.

In recent drought conditions, Bayer CropScience has supported farmers across Australia with a dedicated and professional team.

For information on Bayer CropScience’s financial results see pages ��-�3.

Milestones • Cheetah® Gold became the best

performing cereal herbicide (in budget achievement) in its first year in tough market conditions.

• Basta®, a very well established herbicide, achieved its highest ever recorded sales in a calendar year.

• Oberon® launched in New Zealand for control of whitefly and spider mites in glass house tomatoes, cucumbers and ornamentals.

• Liberty Link® Cotton was launched into the cotton market in May, making Australia the second country globally to launch a Bayer biotech product in this crop.

• New label claim granted for Poncho® in New Zealand pasture for protection against Argentine stem weevil and grass grub.

• Maxforce® Liquid Ant Bait was launched into the professional pest control market in April.

Areas of expertiseBayer CropScience operates in these major areas:

Crop Protection manufactures and supplies high performance, trusted and innovative products to agricultural producers in the broadacre, horticulture and cotton markets.

Environmental Science covers both professional and consumer pest control in an array of markets across Australia and New Zealand. The division aims to minimise the impact of insects, weeds, fungi and other pests in the urban environment by providing highly effective, innovative products that are easy and safe to use.

BioScience uses plant biotechnology and modern plant breeding techniques to improve the quality of crops, increase yields and create sustainable solutions to meet the increasing global need for food, feed, fibre and fuel.

CropScience 07


Innovation in cottonLiberty Link® Cotton and Liberty® Herbicide are a powerful seed and herbicide combination for weed management in cotton production.

Liberty Link® Cotton is genetically modified to be tolerant to Liberty® Herbicide, allowing for effective weed control in cotton.This innovative technology, developed by Bayer CropScience in partnership with the CSIRO and sold through an exclusive technology licence agreement, offers growers a new way to control weeds in cotton. Liberty Link® Cotton is Bayer CropScience’s first genetically modified crop to be made available in Australia. Its introduction into the farming environment, along with Liberty® Herbicide, represents a significant innovation in Australian agriculture.

Twynam’s Manager Chris Barry of Gundaline Station, Carathool, again grew Liberty Link® Cotton on a commercial scale this season after

the success of last season’s seed increase block grown for Cotton Seed Distributors (CSD).

Chris explains, “The decision to plant any cotton this season hasn’t been an easy one. With cotton prices still relatively low and the corn price extremely attractive, and adding to that our high freight cost to get cotton to a gin, corn comes out the winner on gross margin. We had to weigh up the water calculations on each crop and the situation of having all our eggs in the one basket. With corn we were going to make water usage very tight, hence planting an area of cotton was a good risk management tool.

“With the decision made to spread our risk and plant cotton, the next

question was what variety to plant. We had to weigh up all the positives and negatives such as resistance management, controlling Roundup Ready® cotton volunteers, and last season’s yield data. The decision was pretty easy to grow Liberty Link® Cotton on a commercial scale again this cotton season.”

BioScience General Manager Rob Hall says, “Our cotton operations in Australia are a prime example of successful teamwork from BioScience and CropScience colleagues, jointly creating new business opportunities. Liberty Link® Cotton is a welcome solution for Australian cotton growers and is an exciting new direction for Bayer CropScience in Australia.”

08 CropScience

A pipeline of innovation for now and the future Bayer CropScience has plans to launch innovative new solutions into the market this year and each year well into the next decade. These include the introduction of new active ingredients, as well as the modification of existing products to extend them into new crops and control additional pests, weeds or diseases. Bayer CropScience’s innovation pipeline is filled with new modes of action, formulations and label extensions.

Bayer CropScience will launch six new active ingredients between �008 and �0�� – more than any other research and development organisation in Australia and New Zealand.

In New Zealand, Bayer CropScience will be introducing at least �3 new products between �008 and �0��.

They include eight new fungicides, four new herbicides and two new insecticides.

2007March - Cheetah® Gold an innovation in cereal herbicides developed locally for Australian conditions, launched.

May - Liberty Link®, Bayer’s first genetically modified seed and herbicide combination for cotton, launched.

2008Precept®, a new mode of action cereal herbicide, will hit the Australian market. Precept will be a resistance breaker, controlling resistant weeds in cereals.

Atlantis® OD and Hussar® OD will use novel formulation technology to enhance herbicide retention, spreading, and uptake.

ODesi® fluid power formulation technology improves three key application areas of retention, spreadability and uptake of herbicides.

Jockey® Stayer is the newest seed treatment innovation in Australia. Easier to apply to seed, it results in more even seed coverage.

BELT®, an insecticide for Lepidoptera (caterpillar) control in a range of vegetable crops. BELT® delivers a new mode of action.

SickleTM 540 is an aquatic-friendly glyphosate formulation for use in the knockdown weed control herbicide segment.

Rodilon®, the most recently developed active ingredient, rodent control in a ‘soft block’ formulation.

Confidor® 200SC for the control of the exotic pest, currant lettuce aphid, is expected to be registered soon.

2009Movento® is an insecticide for the control of sucking pests. It has a new mode of action for use in a range of vegetables, citrus, mangoes and cotton.

Prothioconazole is currently successful in Europe under the Proline® brand. This cereal fungicide is expected to challenge current standards.

A new broad spectrum broadleaf herbicide for cereals is being developed for wheat and barley.

2010 and beyondA new chemistry group fungicide with a new mode of action for use in nuts and other horticultural crops is under development.

Three herbicides have been developed at the Bayer herbicide research centre in Frankfurt. These are waiting in the wings for further development locally.

Canola plants produce oil with a highly desirable fat profile for use by food manufacturers. Naturally low in saturated fats and high in mono-unsaturates and omega-3 fatty acids, canola oil is a healthier alternative to other fats.


Canola crops giving better results to farmers, manufacturers and consumersThrough partnerships and innovation in canola, Bayer CropScience is helping Australian farmers produce better quality canola plants.

Thanks to the lifting of the moratoria on the commercialisation of genetically modified canola, farmers in Victoria and New South Wales now have a choice to access biotech canola varieties that are safe, profitable and environmentally friendly.

Farmers’ groups have supported the availability of genetically modified canola. The NSW Farmers Association believes “this development is possibly the start of a new chapter in Australian Agriculture.” The Victorian Farmers Federation (VFF) has also campaigned to provide farmers

with access to leading agricultural technology. “It is good to see,” said VFF President Simon Ramsay.

Bayer CropScience is the leading hybrid canola seed business globally, with InVigor® hybrid canola launched �0 years ago in Canada. Bayer has been involved in Australian trials of biotech canola for the past �� years and will continue to be through its government approved research and innovation programs. Biotech canola was initially approved by federal authorities in Australia in �003.

InVigor® is a reliable hybrid canola that delivers higher yields and

is tolerant of the new herbicide Liberty® for broadacre farming.

General Manager for BioScience Rob Hall says, “While we will not have commercial quantities of seed available in �008, we will be focused on generating data to support our new varieties.”

Bayer has proven expertise in oilseeds breeding. It is committed to delivering products that meet market specifications worldwide, principally for higher yields. In the future this new expertise will deliver high quality canola varieties to Australian farmers.

CropScience 09


Farmer Tony Beck (left) and Kyle Gross from Bayer CropScience check the quality of flowering canola plants in Australia.

This photo was used on the cover of Bayer’s Annual Report �007/�008.

0�0 MaterialScience

MaterialScienceBayer MaterialScience is one of the world’s largest producers of polymers and high-performance plastics. With 30 production sites and �5,000 employees worldwide, it manufactures high tech polymer materials and develops innovative solutions for products used in many areas of daily life.


Bayer MaterialScience’s developments in adhesives, coatings, polycarbonates and polyurethanes significantly enhance life for almost everyone in our community. New uses are regularly made with interest coming from the architectural and safety markets, the mining industry and creative designers.

Bayer MaterialScience also stands for know-how and expertise. With growth products, excellent technologies and a well-stocked innovation pipeline, Bayer MaterialScience aims to extend its market leadership. Our people, society as a whole and the environment are as important as the well being of the company in the pursuit of this goal.

Bayer MaterialScience’s financial results are detailed on pages ��-�3.

Areas of expertiseBayer MaterialScience has six divisions:

Adhesives

Supplying raw materials with excellent resistance properties, tailor made adhesives can be used in a broad range of industries including automotive, construction, footwear and furniture.

Coatings

Based mainly on polyurethane chemistry, high-performance industrial coatings are used in a wide range of everyday consumer goods, ranging from paper, film and textiles to wood and glass.

Polycarbonates

Makrolon® is one of Bayer’s strongestand best-known brands. It is the largestpolycarbonate producer in the world andBayer’s association in the fast growingAsiaPacific market is reflected in stateof the art facilities in Thailand and China.This high-tech material is used in adiverse range of applications includingcar headlamps, glazing, water bottlesand protective wear.

PolyurethanesDiscovered 60 years ago, polyurethanes are a part of our daily life. Whether in mattresses, car seats, refrigeration insulation or leisure footwear the potential uses of this product are almost limitless.

Thermoplastic Polyurethane

Desmopan and Texin® have the combined characteristics of rubber and plastic. Their properties can be tailored to a large variety of applications that include automotive, sports and leisure, electrical and industries operating in extreme conditions such as the offshore oil industry.

Laserlite Australia Pty Ltd

A subsidiary of Bayer, Laserlite is the leading Australian-based manufacturer of polycarbonate roofing, wall cladding and polycarbonate solid sheet.

In �007 Laserlite completed the commissioning of the new extrusion line, which will provide added capacity for Polycarbonate Corrugated Sheet and the capability to manufacture a broader range of Polycarbonate Solid Sheet. A recent agreement with Eastman Chemicals will provide access to both the domestic and export markets for PETG solid sheet.

As part of the Bayer Semi Finished Products group, Laserlite actively pursues business development opportunities through the global group, such as Laserlite’s market launch of Makrolon® Bullet Resistant and Abrasion Resistant sheet.

These can be used for security and architectural glazing applications. Now marketed and distributed by Laserlite, these sheets are complementary to the Polycarbonate Solid Sheet products manufactured on the new extrusion line.

Milestones for 2007• Divestment of Wolff

Cellulosics.

• Desmopan was successful in the application of tactiles for the health and safety industry.

• In conjunction with Bayer Thailand, developed a new grade of Makroblend® for the electrical industry.


MaterialScience 0��

Bayer’s meeting room and bar at the Kfair Trade Show �008 that showcased the KaynemaileTM Seamless Mesh as a modern surface solution. Seen here in Ice Blue from the translucent range.

An inventive use of an innovative polycarbonateKaynemaileTM is a seamless meshmanufactured in New Zealand fromMakrolon® polycarbonate. Produced byBayer MaterialScience, Makrolon® is a high performance polycarbonate that ensures the KaynemaileTM meshes are of the highest quality. KaynemaileTM has an exciting development history. New Zealand process inventor (and owner of Kaynemaile Limited) Kayne Horsham had never previously worked with chainmail until he found himself Art Director for Creatures, Armour and Weapons for the Lord of the Rings film trilogy. For the movies, costume chainmail had to be lightweight, yet robust enough to withstand the demands of filming. “First we tried steel chainmail tunics. But they weighed about 30 kilograms, so it was impossible for the actors to wear them for any length of time,” Kayne says.

The first solution was a mesh of hand-made plastic rings with an electroplated metal covering that was light, but not durable. Next, KaynemaileTM developed an ‘automated knitting machine’. However, this was unable to interconnect the rings seamlessly. “With �5,000 joins per square metre, we had a lot of potential weak points,” says Kayne.

Success finally came when the company developed a completely new approach to injection-molding. New technology invented by KaynemaileTM allows parts to be created seamlessly within multiple other parts to form a �D network. Each link in KaynemaileTM mesh is created as a solid shape resulting in a seamless structure with no joins or inherent points of weakness. KaynemaileTM is the only company in the world to perfect this process, which is protected by multiple international patents, trade secrets and trademarks.

“Makrolon® polycarbonate makes the product lightweight, but still strong and durable,” explains Justin Gleeson, Bayer MaterialScience Technical Manager. The properties of Makrolon® also mean KaynemaileTM mesh is fire-resistant (self-extinguishing), UV stable, chemical and impact resistant, and unlike traditional chainmail is not susceptible to rust when exposed to the elements.

KaynemaileTM has much broader applications than the design sector. It also has many possibilities in industrial applications, such as filter systems and conveyor belts, cargo nets or for wind protection.

AspirinThe world’s best known painkiller

was invented by Bayer in �899.


0�� Our products


Betaferon®

Treats people with multiple sclerosis.

Canesten®

A highly trusted range of antifungal treatments, Canesten® provides a range of products for the treatment of thrush and other skin fungal infections.

Yasmin®

Bayer Schering Pharma’s best selling oral contraceptive.

Advocate®

A broad protection against common internal and external parasites for dogs and cats. Application is stress-free for pets, owners and veterinarians.

Berocca®

An everyday energy supplement with vitamins B and C, calcium, magnesium and zinc.

Zapp®

Zapp Pour-on is an insect growth regulator pour-on lousicide for the control of sheep body lice.

Elevit®

A vitamin and mineral supplement formulated for the expectant mother and her growing baby from conception, through pregnancy and onto breast-feeding.

Profender®

The world’s first broad-spectrum gastro-intestinal worm treatment for cats with simple stress-free spot-on application.

Our products

Systematic research over more than a century has been the basis of the success of Bayer’s current portfolio of some 5,000 products. This is a selection of products from the company that invented Aspirin.

Our products 0�3


Confidor®

Controls sap sucking insects on ornamentals and green peach aphid on stone fruit and vegetables.

Makrolon®

A lightweight, break-resistant, non-splintering, transparent plastic and much more. Renowned for meeting highly specialised requirements.

Maxforce®

Innovative bait solutions for the control of crawling insect pests

DesmopanA thermoplastic polyurethane that readily bonds to a variety of substrates. Provides a soft-touch feel and offers designers a versatile material.

Precept®

Using a new mode of action, Precept®

herbicide will be a resistance breaker, controlling resistant weeds in cereal crops.

Desmodur®

This resin gives polyurethane coatings their versatility, durability and high performance characteristics.

Basta®

A herbicide for non-residual control of broadleaf and grass weeds in various situations, Basta® is now in �0 litre easy to handle packs.

Laserlite Apollo®

Polycarbonate corrugated roofing with high impact resistance, excellent transparency, ultra-violet protection, heat-reflectiveness and fire resistance.

Spotlight on New ZealandInnovation was the main theme of Bayer’s business operations in New Zealand throughout �007. As well as launching several new and innovative products, Bayer New Zealand decided it was time that some of the country’s most innovative individuals were recognised for their efforts.

This is Bayer 2007/08 This is Bayer 2007/08

0�4 Bayer New Zealand

To do this, Bayer teamed up with the National Business Review (NBR) and developed the Bayer Innovators Awards. The aim was to find 60 leading innovators across six categories ranging from manufacturing to agriculture and the environment.

Six overall winners were then chosen by an independent judging panel and acknowledged at a cocktail function, as well as through the editorial pages of the NBR.

The awards will again be held in �008.

Other Bayer New Zealand highlights from throughout �007 include:

Bayer HealthCare• Consumer Care division received the

supplier of the year award from the pharmacy trade.

• Launch of Bepanthen First Aid® antiseptic cream.

• Launch of Canesten Duo® and Canesten Oral® for rapid treatment of vaginal thrush.

• Launch of sugar-free Berocca®

Performance range.• Registration of Nexavar® for treating

renal cell carcinoma.• Global Bayer haemophilia research grant

worth more than NZ$�00,000 awarded to Christchurch doctor Mark Smith.

• Launch of new range of parasite management products by Animal Health division.

Bayer CropScience• Launch of 0800 ASSIST— a new

information service for customers.• New label claim granted for FLINT®

for scab control in citrus.

• FLINT STAR® launched for control of black spot in apples.

• New label claim granted for Teldor® for botrytis control in citrus.

• Oberon® launched for control of whitefly and spider mites in glasshouse tomatoes, cucumbers and ornamentals.

• New label claim granted for Poncho® in pasture for protection against Argentine stem weevil and grass grub.

• Insecticide Proteus® launched in onions for onion thrips control.

Bayer MaterialScience• Use of Bayer plastics Makroblend®

and Desmopan in the new range of hand-held radio equipment from Tait Electonics.

• Successful use of Desmopan in airbattens used by several America’s Cup boats.

Key sponsorships• Renewal of NZ$�4,000 three-year

sponsorship of the Whangarei Native Bird Recovery Centre.

• Selection and sponsorship of three university students to attend the Eco-Minds youth forum in Thailand as part of Bayer’s global partnership with the United Nations Environment Programme.

• BAYERBoost environmental scholarship scheme run in partnership with the Royal Society of New Zealand. Worth NZ$40,000, the scheme funds students to work in the area of environmental restoration or protection.

• Signed up as a gold sponsor of United Way New Zealand, a charity that supports small to medium-sized community charities throughout New Zealand.

Dairy farmers, Russell Davenport and Phil James, with Dr Louise Coats veterinarian.

Relationships built on trust and high quality productsKeeping animals fit and healthy, both on the farm and at home, has been a big part of Bayer New Zealand’s business over many years.

Bayer New Zealand 0�5

An essential component of doing agricultural business is maintaining a close working relationship not only with farmers, but rural distributors and veterinarians too.

A good example of this is the long-time relationship Bayer has with FVC Veterinary Services, located in the Thames/Hauraki area south of Auckland.

Along with many other dairying areas in New Zealand, the region is currently enjoying a dairying boom making it even more important that dairy cows are kept in peak health.

With regional manager Janie Martin located in the heart of the area, Bayer is able to offer quick, efficient service and advice on a wide range of animal health issues.

For example, copper deficiency has been recognised as a production-limiting problem in New Zealand since the �940s. It is caused by a shortage of copper in the soil and pasture, which is subsequently passed onto the animal.

Bayer Animal Health’s Copper Capsules are therefore important for farmers in the region as are other Bayer products such as the calcium and magnesium supplement Calform® Plus and Baycox® C for treating Coccidiosis in calves.

It’s not only large farm animals that benefit from Bayer products, but small animals too. As well as supplying medicines and supplements for the farm, Bayer also keeps many of New Zealand’s pets free of fleas and worms with products such as Advantage® and Drontal®.

Veterinarian Dr Louise Coats from FVC Veterinary Services in Ngatea says it’s important when dealing with large companies such as Bayer that you have quick and prompt services.

“With the current dairy boom, cows are an expensive commodity that need to be looked after. What’s good about Bayer is that they have a local rep who looks after our needs really well, which in turn allows us to meet the needs of local farmers.

“When we have a problem we always know there is someone there we can call up,” she adds.

For more information about Bayer Animal Health, visit www.animalhealth.bayer healthcare.com


Our peoplePeople are integral to Bayer’s success. Bayer is recognised for its commitment to creating satisfying and fulfilling work lives for employees.

0�6 Our people

Bayer’s mission statement, Science For a Better Life, applies to the people who make up the company as well as to partners and customers. Bayer seeks to nurture its talented employees and help them create better lives for themselves.

Pictured below is Bayer’s people strategy. The three components of this are:

Achieving your personal bestBayer works with its people to help them fulfill their ambitions and to ensure that the right people are in the right job. This benefits employees and ensures business goals are met.

Creating a great place to workMany things go into creating a great place to work including getting the recruitment right, excellent leadership, and a positive culture and climate.

Refining people systemsA commitment to quality people systems supports the work of the business. This encompasses good human resources information systems and knowledge management as well as a commitment to business partnerships.


Bayer Spirit Commitment and passion, curiosity and a thirst for knowledge: that’s the Bayer Spirit.

The Bayer Spirit is employees working toward making a better life through innovation.

Phuong Tran

Our people 0�7

John Oulton

Stuart McLaverty Judy Ellmers

Achieving your personal best

Phuong TranAssociate Product Manager, Bayer Schering Pharma, Bayer HealthCare

Joining Bayer as part of the merger with Schering in �007, Phuong Tran has recently moved to a marketing role for the oral contraceptive pill, Valette®. Phuong has enjoyed the shift. “Even though I have a long background in the Women’s Health division, I am new to marketing,” she says. “It’s great to have a new challenge.” Phuong has appreciated the direction and support of her managers in achieving her work goals at Bayer. “I am able to get on with my work knowing that there is good guidance available to help me achieve my personal best,” she says.

Phuong is also pleased that her managers have enrolled her in Bayer Interactive Management Systems (BIMS), a Bayer-wide management program.

John OultonBusiness Development Manager, Animal Health, Bayer HealthCare

Recently John Oulton took some initiative to improve Bayer’s Animal Health business.

In his four years with Bayer in Queensland John had some ideas for the Animal Health business and made a proposal for a business development role.

John’s initiative was not just appreciated. He was

asked to undertake a pilot program by taking on the role himself. John says, “Building this role from scratch has given me great exposure to other

parts of the business which has helped me understand where more opportunities might lie for Animal Health, as well as enabling me to achieve my personal best.”

Creating a great place to work

Stuart McLavertyBusiness Manager, Horticulture and Summer Crops, Bayer CropScience

Variety and having the freedom to operate are things that Stuart McLaverty values highly in his work as Business Manager, Horticulture and Summer Crops. “There is nothing dull or mundane about work for me or my team.” It’s this team that Stuart says is another major reason Bayer is a great place to work, saying that everyday he enjoys working with fantastic people.

Stuart also appreciates working in a global framework saying, “This is a business where you are

encouraged to grasp the bigger picture and are given lots of ability to work within that.”

Stuart appreciates the type of leadership at Bayer where people are supported and encouraged to make their own decisions and both individual and team contributions are recognised.

“We were able to acknowledge the team’s fantastic results with Basta® last year,” says Stuart, referring to the record sales of the herbicide.

Judy EllmersAccounts Payable Officer - Overseas, Bayer New Zealand

Managers who recognise strengths and shape job roles to suit them is the reason Judy Ellmers cites for her �8 year career with Bayer. “My role has evolved so much over the years that I have always had interesting work at Bayer. And that’s thanks to excellent leadership,” says Judy.

Judy loves the good rapport between the teams in New Zealand. “People make an effort to get on and when there are issues they are resolved quickly.” Relationships are clearly what creates a great place to work for Judy and her attitude to people has a positive effect on her workplace. She says, “We have always been encouraged in Corporate and Business Services to think of people as internal clients who need the same great service as external clients.”


0�8 Community and environment

Community and environmentBayer has a long history of commitment to the communities in which it does business. From the global programs with UNEP (United Nations Environment Programme) to local initiatives like the GIVE Program, Bayer globally contributes millions of dollars each year to social and community projects.


The Bayer Climate Change ProgramLate in �007 Bayer announced its global Climate Change Program aimed at reducing the company’s greenhouse gas emissions by �0�0. Ambitious emission targets were set for each subgroup (eg �5% for Bayer MaterialScience) depending on each activity and business.

Bayer has already begun work on environmental projects across the globe. For example, in New Delhi (India) an eco-commercial building insulated with products from Bayer MaterialScience will emit zero emissions. Additionally, the work in Bayer CropScience focuses on biofuels and on stress-resistant plants that increase yield per hectare. This should then provide more hectares for energy plants. In fact, the Jatropha plant is a biofuel that can be grown in areas too hot or arid for food crops and so does not compete with crops required to feed the world.

As part of the climate program, the Bayer Climate Award offers EUR 50,000 every two years to researchers who develop groundbreaking solutions for climate protection. The Bayer Climate Fellows Award offers EUR 5,000 to school students to help them attend seminars and increase their education in the climate arena. In �008, these Fellows will be chosen from German students. It will extend internationally from �009.

Locally, Bayer Australia and New Zealand will extend their own contribution to the Climate Program. The Greenhouse Challenge, in conjunction with the Australian government (page �0), is part of this contribution.

The GIVE ProgramSince �005 in Australia and �006 in New Zealand, Bayer has contributed nearly A$340,000 (NZ$385,000) to charities and communities across both countries. This amount is in addition to those funds raised and donated by employees. In Australia, Bayer partners with Mission Australia who helps to create a better life for disadvantaged families. In New Zealand, Bayer’s work with United Way helps small and medium charities who would not otherwise have the resources.

The GIVE Program comprises four elements:

�. Matched giving – any fundraising made by employees to a registered charity is matched by Bayer up to $�,000.

�. Give as you earn – Bayer matches employee donations to their favourite charities (pre-tax) direct from employees’ salaries.

3. GIVE sponsorship – Bayer sponsors community activities in which employees and their families are involved.

4. GIVE leave – one day’s paid leave each year to spend working in the community.

A snapshot of 2007 for the GIVE Program

�. Bayer matched A$16,500 (NZ$18,800) of employees’ fundraising efforts.

�. A$31,000 (NZ$35,000) donated per year directly from employees’ salaries (matched by Bayer).

3. Employee community activities were sponsored for A$14,400 (NZ$16,400).

4. 138 days paid leave to volunteer in the community.


Community and environment 0�9

30 employees across Australia spent the day

selling merchandise for The Cancer Council

on Daffodil Day.

In Sydney, the Human Resources team spent the day helping Canteen pack boxes for Bandanna Day.

BBQ with Mission Australia clients at a local park.

Over two years Bayer employees raised more than $8,000 for the Leukaemia Foundation in the World’s Greatest Shave. Each year $�,000 of this was matched by Bayer.

Restoring native vegetation on Motuihe

Island has become a favourite volunteering

activity in Auckland.

Bayer is improving its energy efficiency and reducing its greenhouse gas emissions, while increasing returns on investment.


0�0 Community and environment

The Greenhouse ChallengeThrough the Greenhouse Challenge, a partnership between the Australian government and industry, Bayer has committed to appropriate, practical and

cost-effective actions to reduce its own greenhouse gas emissions.

The Greenhouse Challenge is designed to reduce emissions, accelerate the uptake of energy efficient practices, integrate greenhouse issues into business decision-making and provide more consistent reporting of greenhouse gas emissions levels.

Bayer is also encouraging both its people and external stakeholders to implement their own actions. The ME-3 program (My environment now and over the next three generations) supports Bayer employees and their local communities to commit to sustainable development. Formed around the three ideals of Reduce, Re-use and Recycle, ME-3 provides tips, challenges, and education on a broad range of environmental topics.

Undertakings in the Greenhouse Challenge

Bayer is committed to reducing emissions, and to support this has made a number of undertakings. Some examples are:

• Conducting lighting and energy audits of offices to identify ways to reduce power usage. Potential remedies include timers, more efficient air conditioning and turning unused equipment off.

• Reviewing the motor vehicle policy to include smaller and more fuel efficient vehicles as well as hybrids or diesel vehicles.

• Expanding existing recycling programs to all sites (paper, aluminium, plastic, toner cartridges).

• Reviewing the purchasing policy to include organisations that supply recycled products.

• Signing the National Packaging Covenant, thereby reducing unnecessary packaging wherever possible.

During the worldwide One Billiion Trees campaign, Bayer planted over �000 trees in Australia and New Zealand.

At Australia Walkabout Park, Bayer planted ��0 rare Wollemi Pines replicating the original colony of these recently-

discovered “dinosaur” trees. Pictured above (left to right) Tassin Barnard, Australia Walkabout Park; John Dee,

Planet Ark; and Michael Walleneit, Bayer.

Management reportIt was a successful year for Bayer in Australia and New Zealand despite some difficult trading conditions. Globally, the company experienced its �0th quarter-on-quarter growth.


Management report 0��

Total revenue for both countries was EUR 436 million. This equates to A$7�3 million or NZ$8�� million. This compares very favourably to the previous year, acknowledging that �007 was the first time that Schering sales were included for the full year.

Bayer HealthCare

Bayer HealthCare performed well with sales in �007 of A$396 million (NZ$45� million), an increase of 85% over �006. It is important to remember that �007 is the first time that Schering sales have been included for a �� month period. A number of new products were launched successfully and some established brands had excellent sales results. Bayer Schering Pharma and Consumer Care had very positive results with Consumer Care performing well above the market. Animal Health performed well despite the effects of drought in Australia.

The post-consolidation period of the new Bayer Schering Pharma business has progressed well, achieving our �007 revenue target. Betaferon® continues to be Bayer Schering Pharma’s largest selling medication in Australia and the number one treatment for people with multiple sclerosis. New Zealand’s highest selling pharmaceutical product is Kogenate® for haemophilia.

Ultravist 370®, a contrast enhancement for computerised tomography, was relaunched and is performing well. Following its launch in Australia late in �006, Valette®, oral contraceptive, has had good sales. Mirena®, an IUS for long-term contraception and a treatment for idiopathic menorrhagia, also did well.

Consumer Care exceeded its sales target by �% in �007. This was an ��% increase on the previous year and 3% higher than market. Berocca®, a well established brand, had excellent sales growth of �3% on the

previous year. Elevit®, a vitamin supplement for pre-conception, pregnancy and breastfeeding doubled sales in one year.

Bayer Animal Health increased revenue 6.4% over the previous year although the impact of drought on the Australian livestock industry meant only 95% of the sales target was met. The New Zealand target was exceeded by ��%. Sales of companion animal products increased across the board with Bayer becoming the market leader in the companion animal business in Australia.

Bayer CropScience

As can be expected, the financial performance of Bayer CropScience was seriously affected by the long-term drought in Australia. Sales of A$�88 million (NZ$��4 million) were slightly down on last year, but exceeded mid-year expectations.

After what was a promising start to the season in April, the winter and spring rainfall was not significant enough to help improve on �006 performance. Crop protection sales for �007 were down 5.6% on �006.

Nevertheless, some products, both new and old, performed exceptionally well. Cheetah® Gold in the first year of registration met 97% of budget and Basta® had a record year with sales of this mature product exceeding all expectations.

The Environmental Science business was also affected by the dry weather and water restrictions. Environmental Science sales for �007 were down approximately �0% on the previous year. The continued hot and dry weather bodes well for sales of Maxforce® Liquid Ant Bait, which in its first year of sales performed above expectations.

With Australia suffering severe drought, agricultural production was significantly reduced.


0�� Management report

With wheat production down, commodity prices rocketed to over A$400 per tonne. The outlook for �008 is more positive following the change in weather patterns.

Bayer MaterialScience

Bayer MaterialScience increased revenueby 4% over the previous year. With sales in�007 (excluding Laserlite) of A$60 millionor NZ$69 million, Bayer MaterialSciencewas 3% under budget for �007.

Volume overall in �007 was 5% under budget, although volume increased dramatically in two business areas. Polyurethane volume increased by 4�% due to favourable commodity market conditions and polycarbonate by ��% due to new business development and market gain. Costs were below budget and working capital results continued to show improvements.

Laserlite revenue (A$54 million or NZ$6� million), was influenced by declining market

prices for polycarbonate roofing, despite volume sales increasing by 9% over the previous year. Environmental conditions were also a factor with recent harsh water restrictions and rising interest rates discouraging home owner investment in outdoor entertaining.

Manufacturing in Australia and New Zealand is constantly under pressure from cheaper imports. Furthermore, Bayer MaterialScience is expecting a downturn in the construction sector for �008 due to the volatility of the local stock market and rising interest rates. The booming Australian mining industry will continue to positively affect MaterialScience’s business development.

The trend of industry in Australia and New Zealand is to specialise, and MaterialScience focuses on maintaining and enhancing customer relationships by providing innovative solutions to assist them in the local and international markets.

400

350

300

�50

�00

�50

�00

50

0 �006 �007 �006 �007 �006 �007 �006 �007

Bayer HealthCare Bayer CropScience Bayer MaterialScience LANXESS*

% of total revenue for 2007

56% �6% �6% �%

��3

396

�95 �88

��3 ��5

�� 3

�007

�006

0 �00 �00 300 400 500 600 700 800

2006/2007 Comparison of sales turnover by country and total (A$million) in Australia and New Zealand

• Australia

• New Zealand

A$ million

444

598

93

��5

2006/2007 comparison of sales by subgroup in Australia and New Zealand (A$million)


Management report 0�3

Positive global performance for Bayer AGBayer AG sales rose ��.8% to EUR 3�.4 billion compared to EUR �9 billion in �006. �007 is the first year that the sales from the acquisition of the Schering business have been included in full. EBITDA (earnings before interest, taxes, depreciation, amortisation and special items) grew by ��.4% to EUR 6.7 billion with the underlying EBITDA margin at �0.9% (�006: �9.3%).

Bayer HealthCare achieved the strongest growth among the three subgroups, sales rising by �6.3% year on year to EUR �4.8 billion. Sales in the Pharmaceutical segment rose 37.3% to EUR �0.� billion with business expansion in oral contraceptives, Betaferon®, and Mirena®. In the Consumer Health segment, sales came in at EUR 4.5 billion with growth amounting to �0.3% on a currency-and portfolio-adjusted basis. Strongest gains were in Berocca®, Canesten® and Aleve®.

Business in the Animal Health division increased primarily due to the positive performance of the Advantage® range of flea and tick control products, currency

adjusted sales of which rose by ��%. Diabetes Care grew by �8%, thanks mainly to the outstanding performance of the Ascensia® Contour blood glucose monitoring system.

Bayer CropScience sales of EUR 5.8 billion expanded business by 5.6% after adjusting for currency and portfolio effects. Overall the crop protection business benefited from the positive business conditions on the world’s agricultural markets. Sales advanced 6.3% to EUR 4.8 billion (�006: EUR 4.6 billion).

In the Environmental Science, BioScience segment, sales came to EUR � billion and increased the currency-and portfolio-adjusted by �.6%.

Bayer MaterialScience experienced higher volumes and higher selling prices overall, expanded business by 6.�% on a currency- and portfolio adjusted basis, to EUR �0.4 billion. Sales in the Systems segment climbed by 5.5% on a currency-and portfolio-adjusted basis, to EUR 7.4 billion, while the Materials segment (Polycarbonate and Thermoplastic Polyurethanes) had sales of EUR 3 billion.

2007 Sales by subgroup

Subgroup ANZ1 Sales

A$ Million

ANZ1 Sales

NZ$ Million

Global Sales

EUR Billion

Bayer HealthCare 396 45� �4.8

Bayer CropScience �88 ��4 5.8

Bayer MaterialScience ��5 �3� �0.4

Agency for LANXESS* �3 �5 �.4

Total including other business 713 812 32.4

�Combined Australian and New Zealand figures.

*Bayer New Zealand Ltd continues to act as an agency for LANXESS AG.

8%

16%

21%

55%• Bayer Australia Limited

• Bayer CropScience Pty Ltd

• Bayer New Zealand Limited

• Laserlite Australia Pty Ltd

2007 Revenue by Company or Country in Australia and New Zealand


0�4 Bayer at a glance

Bayer at a glance

BrisbanePinkenba

WyongSydney

MelbourneHorsham

Adelaide

Mount Gambier

PerthKwinana

Offices

Production sites

Research and innovation centresAuckland

Christchurch

Hans-Dieter HausnerSenior Bayer RepresentativeHead of Bayer HealthCare

Joerg EllmannsHead of Bayer CropScience

Andrew WindsorHead of Bayer MaterialScience

Rod KingManaging Director, Laserlite

BrisbanePinkenba

WyongSydney

MelbourneHorsham

Adelaide

Mount Gambier

PerthKwinana

Offices

Production sites


ChristchurchMap not to scale


Bayer at a glance 0�5

Customer service numbers

Division Australia New Zealand

Animal Health �800 678 368 General enquiries – 0800 65� 488Companion Animal enquiries – 0800 446 ��Livestock enquiries – 0800 9�7 733

Bayer Schering Pharma Medical information – �800 673 �70 Customer Service – �800 039 076

0800 �33 9880800 804 545

BioScience +6� 3 9�48 683�

Consumer Care Medical information – �800 0�3 884Customer Service – �800 039 076

0800 847 874

CropScience Customer Service – �800 636 00�Technical enquiries – �800 804 479

0800 4�8 �46

Diabetes Care Customer Service – �800 0�8 �5�

Environmental Science �800 ��3 00�

MaterialScience �800 800 65� 0800 65� 436

LANXESS 0800 653 937

Emergency

In case of an emergency involving Bayer’s products, sites or personnel, please use our �4 hour freecall numbers

�800 033 �� 0800 734 607

735

95

5

376

236

99

16

98

735

95

5

376

236

99

16

98

• Bayer HealthCare

• Bayer CropScience

• Bayer MaterialScience

• Laserlite

• Bayer Corporate and Business Services

• LANXESS

* This includes people working in regional Australia and New Zealand.

• Australia

• New Zealand

Contact Bayer Australia and New Zealand

Business Contact details

Bayer Australia Ltd 875 Pacific Highway, Pymble NSW �073 T +6� � 936� 6000

Bayer New Zealand Ltd 3 Argus Place, Hillcrest, North Shore, Auckland NZ 06�7 T +64 9 443 3093

Bayer CropScience Pty Ltd 39�-393 Tooronga Road, Hawthorn East Vic 3��3 T +6� 3 9�48 6888

Bayer MaterialScience 39�-393 Tooronga Road, Hawthorn East Vic 3��3 T +6� 3 9�48 6888

Laserlite Australia Pty Ltd �7-�9 Wangara Road, Cheltenham Vic 3�9� T +6� 3 958� 9888

Employee numbers by subgroup* Employees by country

BrisbanePinkenba

WyongSydney

MelbourneHorsham

Adelaide

Mount Gambier

PerthKwinana

Offices

Production sites


Christchurch

0� Bayer HealthCare

For further information please contact Corporate Communications

Bayer Australia Limited875 Pacific Highway, Pymble, NSW 2073 AustraliaT +61 2 9391 6000 F +61 2 9391 6111www.bayer.com.au

Bayer New Zealand Limited3 Argus Place, Hillcrest, North Shore 0627, Auckland New ZealandT +64 9 443 3093 F +64 9 443 3094www.bayer.co.nz

Products marked with ® are Registered Trademarks.© 2008 Bayer Australia and New Zealand. All rights reserved.

Printed on 50% recycled paper.

Cover picture: The human population is rapidly expanding worldwide, yet drinking water is becoming scarcer. That’s why Bayer, in cooperation with National Geographic, is supporting research projects on treating, distributing and tapping new sources of water, while also promoting the economical use of this valuable resource. This is just one of 300 examples in which Bayer is demonstrating its commitment to corporate social responsibility.

This is Bayer 2007/2008 · • Elevit ®, a vitamin ... welfare and, if there are benefits to be...

Documents

Transcript of This is Bayer 2007/2008 · • Elevit ®, a vitamin ... welfare and, if there are benefits to be...